Carmine alternatives sales will rise through 2036, driven by the dry form segment at a 58.7% share in 2026. Fruit-based sources hold a 47.9% share of clean-label formulations. The market was valued at USD 25.8 million in 2025 and is expected to reach USD 47.0 million by 2036.